0000921895-23-000702.txt : 20230316
0000921895-23-000702.hdr.sgml : 20230316
20230316180218
ACCESSION NUMBER: 0000921895-23-000702
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230314
FILED AS OF DATE: 20230316
DATE AS OF CHANGE: 20230316
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: EDRICK ALAN I
CENTRAL INDEX KEY: 0001195340
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33957
FILM NUMBER: 23740079
MAIL ADDRESS:
STREET 1: 20200 SUNBURST STREET
CITY: CHATSWORTH
STATE: CA
ZIP: 91311
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HARVARD BIOSCIENCE INC
CENTRAL INDEX KEY: 0001123494
STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826]
IRS NUMBER: 043306140
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 84 OCTOBER HILL RD
CITY: HOLLISTON
STATE: MA
ZIP: 01746
BUSINESS PHONE: 5088938999
MAIL ADDRESS:
STREET 1: 84 OCTOBER HILL ROAD
CITY: HOLLISTON
STATE: MA
ZIP: 01746
4
1
form412799edr_03162023.xml
OWNERSHIP DOCUMENT
X0306
4
2023-03-14
0
0001123494
HARVARD BIOSCIENCE INC
HBIO
0001195340
EDRICK ALAN I
C/O HARVARD BIOSCIENCE, INC.
84 OCTOBER HILL RD.
HOLLISTON
MA
01746
1
0
0
0
Common Stock
2023-03-14
4
P
0
13808
2.67
A
186293
D
Common Stock
2023-03-15
4
P
0
16192
2.62
A
202485
D
This transaction was executed in multiple trades at prices ranging from $2.61 to $2.72, inclusive. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $2.57 to $2.68, inclusive. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
Includes (a) 38,259 restricted stock units that fully vest on the earlier to occur of (i) the date of the Issuer's next Annual Meeting of Stockholders after May 17, 2022, immediately prior to the commencement of such meeting, and (ii) May 24, 2023 and (b) 164,226 shares of common stock held by the Report Person.
/s/ David Sirois, by power of attorney
2023-03-16